Unlocking Q2 Potential of Intuitive Surgical (ISRG): Exploring Wall Street Estimates for Key Metrics

Core Insights - Intuitive Surgical, Inc. (ISRG) is expected to report quarterly earnings of $1.92 per share, a 7.9% increase year-over-year, with revenues projected at $2.35 billion, reflecting a 16.8% year-over-year growth [1] Earnings Estimates - The consensus EPS estimate has been revised upward by 0.1% in the last 30 days, indicating analysts' reassessment of their initial estimates [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Forecasts - Analysts forecast 'Revenue- Product (Instruments and accessories and Systems)' to reach $1.96 billion, a 15.7% increase from the previous year [5] - The consensus estimate for 'Revenue- Services' is $368.86 million, suggesting a 16.3% year-over-year change [5] - 'Revenue- Systems' is expected to reach $516.21 million, indicating a 15.2% increase year-over-year [5] Unit and Procedure Estimates - The average prediction for 'Revenue- Instruments and accessories' is $1.44 billion, reflecting a 15.9% increase from the prior year [6] - Analysts estimate 'Total System Units Placed - Total Company' at 395, up from 341 in the same quarter last year [6] - The estimated 'Total Number of Procedures' is 771,122, compared to 661,000 a year ago [7] - The 'Da Vinci Surgical System Installed Base' is projected to be 10,427, up from 9,203 year-over-year [7] - 'Total System Units Placed - Outside of the United States' is expected to reach 184, down from 192 year-over-year [7] - 'Total System Units Placed - United States' is estimated at 211, compared to 149 in the same quarter last year [8] Profit and Cost Estimates - The consensus for 'Gross profit- Service' is $245.26 million, up from $219.50 million in the same quarter last year [8] - Analysts project 'Cost of revenue- Service' to reach $118.34 million [8] Stock Performance - Over the past month, shares of Intuitive Surgical have returned +0.6%, while the Zacks S&P 500 composite has changed +4.2% [9] - ISRG currently holds a Zacks Rank 2 (Buy), indicating potential outperformance in the near future [9]